|
|
Perhaps the asset of our company that best represents both the distinctiveness and the value of KV as a true specialty pharmaceutical company is our proprietary technology portfolio. Our 15 unique drug delivery systems have enabled the development of a wide-range of differentiated product opportunities for all three of our marketing business units. |